Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Remedies

The Alliance For The Advancement Of Adult Stem Cell Therapy And Research Announces Successful Treatment Of End-Stage Heart Disease With Stem Cells
Zannos Grekos, MD, Associate Clinical Professor at Nova Southeastern University, has announced six month follow-up results for a patient treated with adult stem cells in a clinical study of idiopathic dilated cardiomyopathy. The clinical study is a collaborative effort among physicians at Regenocyte Therapeutic, an American stem cell therapy clinic; researchers and scientists from Theravitae, a biotechnology company from Israel; and physicians from the American Institute for Regenerative Medicine, Dominican Republic.
generic viagra online
PEAK Surgical Introduces PEAK PlasmaBlade(TM) TnA
PEAK Surgical, Inc. announced the launch of the PEAK((R)) PlasmaBlade TnA (Tonsil and Adenoid) tissue dissection device following 510(k) clearance from the U.S. Food and Drug Administration (FDA). This new product is indicated for cutting and coagulation of soft tissue during otolaryngology (ear, nose and throat [ENT]) surgery, including removal of the tonsils and adenoids.
News of the day
ENT And Allergy Initiates A 'First Of Its Kind' Self-Insured Medical Malpractice Program
ENT and Allergy Associates, LLP (ENTA), is pleased to announce the formation of OASIS (i.e., Otolaryngology, Allergy Specialty Insurance Services), a separate company that will be a vehicle to provide Otolaryngology and Allergy Specific medical malpractice coverage. OASIS, which will be domiciled in the State of Vermont, is the first RRG to provide medical malpractice coverage exclusively to ENT physicians and Allergists. ENTA decided to embark on this path as a means of stabilizing its malpractice premiums in the face of mounting deficits among the State"s largest carriers and the failure of the legislature to pass any meaningful tort reform. These factors will most likely result in substantial premium increases well into the future. In addition, ENTA, now a 96 physician practice, will be able to focus on controlling the risks unique to its specialty to ensure patient safety and physician compliance with its risk management policies.
Medical Devices

World Premiere Of Innovative Medical Devices For Neurosurgery

Renishaw, a world leader in engineering technologies, is introducing an exciting range of high precision systems for functional and stereotactic neurosurgery at the 15th Quadrennial Meeting of the World Society for Stereotactic and Functional Neurosurgery (WSSFN) taking place in Toronto, Canada, from May 24th to 27th 2009. These include the neuromate® surgical robot, and image-guided stereotactic technologies, some of which are still in development. To mark the formal introduction of Renishaw"s neurosurgical portfolio at WSSFN, the company will also be hosting a special satellite event at the Toronto Cricket Club on Sunday May 24th. Two leading neurosurgeons will give lectures about their experiences with surgical robotics and other new stereotactic technologies, and their vision for their future use. Dr Olivier Delalande, Paediatric Neurosurgeon at the Fondation Rothschild Hospital in Paris, France, will discuss his pioneering use of the neuromate stereotactic robot to perform paediatric procedures including Stereo Electro-Encephalography (SEEG) for epilepsy, and neuroendoscopic disconnection for hypothalamic hamartoma. From Frenchay Hospital in Bristol, England, Professor Steven Gill, who is well known for his pioneering work in placing Deep Brain Stimulation (DBS) leads, will also discuss the clinical applications of new technologies in the targeted delivery of therapeutics and their drive towards the requirement for advanced stereotactic systems. Speaking about his company"s first appearance at WSSFN, Sir David McMurtry, Renishaw"s Chairman and Chief Executive, said, "Our commitment to the neurosurgical market is built around listening to the needs of our clinical customers and then delivering advanced precision systems to meet their requirements. We are passionate about our products and ever mindful of the impact that they can have on patients" lives." Guests at the Toronto Cricket Club event will also have the opportunity to see Renishaw"s new products and watch a cricket match whilst enjoying a buffet luncheon. WSSFN delegates who would like to attend can register at www.renishaw.com/toronto or email neuro@renishaw.com. Renishaw plc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009